BRPI0519057A2 - derivados de hidantoÍna éteis como inibidores de metaloproteinase - Google Patents
derivados de hidantoÍna éteis como inibidores de metaloproteinaseInfo
- Publication number
- BRPI0519057A2 BRPI0519057A2 BRPI0519057-6A BRPI0519057A BRPI0519057A2 BR PI0519057 A2 BRPI0519057 A2 BR PI0519057A2 BR PI0519057 A BRPI0519057 A BR PI0519057A BR PI0519057 A2 BRPI0519057 A2 BR PI0519057A2
- Authority
- BR
- Brazil
- Prior art keywords
- derivatives useful
- hydantoin derivatives
- metalloproteinase inhibitors
- inhibitors
- methroproteinase
- Prior art date
Links
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 title abstract 2
- 150000001469 hydantoins Chemical class 0.000 title 1
- 239000003475 metalloproteinase inhibitor Substances 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical class O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
DERIVADOS DE HIDANTOÍNA éTEIS COMO INIBIDORES DE METALOPROTEINASE. A invenção refere-se a um composto de Fórmula (I) onde R¹ é um alquil (C2-4) e é substituído por dois ou mais 2 grupos fluor e R é metil ou etíl, ou um sal farmaceuticamente aceitável deste; a processos para sua preparação, a composições farmacêuticas os contendo e a seu uso no tratamento de doenças ou condições médicas mediadas por enzimas inetaloproteinase.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0427403.1A GB0427403D0 (en) | 2004-12-15 | 2004-12-15 | Novel compounds I |
| PCT/GB2005/004811 WO2006064218A1 (en) | 2004-12-15 | 2005-12-14 | Hydantoin derivatives useful as metalloproteinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0519057A2 true BRPI0519057A2 (pt) | 2008-12-23 |
Family
ID=34090044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0519057-6A BRPI0519057A2 (pt) | 2004-12-15 | 2005-12-14 | derivados de hidantoÍna éteis como inibidores de metaloproteinase |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US8129412B2 (pt) |
| EP (1) | EP1828166B1 (pt) |
| JP (1) | JP5042849B2 (pt) |
| KR (1) | KR20070090921A (pt) |
| CN (1) | CN101080402B (pt) |
| AR (1) | AR051797A1 (pt) |
| AU (1) | AU2005315459B2 (pt) |
| BR (1) | BRPI0519057A2 (pt) |
| CA (1) | CA2589525A1 (pt) |
| CY (1) | CY1109376T1 (pt) |
| DE (1) | DE602005015617D1 (pt) |
| DK (1) | DK1828166T3 (pt) |
| ES (1) | ES2328836T3 (pt) |
| GB (1) | GB0427403D0 (pt) |
| HR (1) | HRP20090489T1 (pt) |
| IL (1) | IL183590A0 (pt) |
| MX (1) | MX2007006744A (pt) |
| NO (1) | NO20073550L (pt) |
| NZ (1) | NZ555684A (pt) |
| PL (1) | PL1828166T3 (pt) |
| PT (1) | PT1828166E (pt) |
| RS (1) | RS51193B (pt) |
| RU (1) | RU2388758C2 (pt) |
| SA (1) | SA05260406B1 (pt) |
| SI (1) | SI1828166T1 (pt) |
| TW (1) | TW200634001A (pt) |
| UA (1) | UA89067C2 (pt) |
| WO (1) | WO2006064218A1 (pt) |
| ZA (1) | ZA200705068B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2610258T1 (sl) | 2007-10-19 | 2014-12-31 | Boehringer Ingelheim International Gmbh | Substituirani piperidino-dihidrotienopirimidini |
| WO2009138777A1 (en) * | 2008-05-12 | 2009-11-19 | Astrazeneca Ab | Process for the preparation of alkoxy-phenoxy-pi peridine |
| US7759512B2 (en) | 2008-07-21 | 2010-07-20 | 3M Innovative Properties Company | Aqueous methods for making fluorinated sulfonate esters |
| CN102234287B (zh) | 2010-04-26 | 2015-08-05 | 上海阳帆医药科技有限公司 | 硝基咪唑类化合物、其制备方法和用途 |
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| US8841487B2 (en) | 2010-07-16 | 2014-09-23 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| NZ705225A (en) | 2010-07-16 | 2016-11-25 | Abbvie Bahamas Ltd | Process for preparing antiviral compounds |
| HUP1300139A2 (en) | 2013-03-06 | 2014-09-29 | Richter Gedeon Nyrt | Phenoxypiperidine h3 antagonists |
| US20160364553A1 (en) * | 2015-06-09 | 2016-12-15 | Intel Corporation | System, Apparatus And Method For Providing Protected Content In An Internet Of Things (IOT) Network |
| GB201610056D0 (en) * | 2016-06-09 | 2016-07-27 | Galapagos Nv And Laboratoires Servier Les | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9919776D0 (en) | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
| ES2281346T3 (es) | 1999-06-04 | 2007-10-01 | Astrazeneca Ab | Inhibidores de metaloproteinasas. |
| EP1261590B1 (en) | 2000-02-21 | 2012-04-11 | AstraZeneca AB | Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0301922D0 (sv) | 2003-06-27 | 2003-06-27 | Astrazeneca Ab | Novel compounds |
-
2004
- 2004-12-15 GB GBGB0427403.1A patent/GB0427403D0/en not_active Ceased
-
2005
- 2005-12-14 AU AU2005315459A patent/AU2005315459B2/en not_active Ceased
- 2005-12-14 UA UAA200706159A patent/UA89067C2/ru unknown
- 2005-12-14 RS RSP-2009/0397A patent/RS51193B/sr unknown
- 2005-12-14 PT PT05818265T patent/PT1828166E/pt unknown
- 2005-12-14 MX MX2007006744A patent/MX2007006744A/es active IP Right Grant
- 2005-12-14 NZ NZ555684A patent/NZ555684A/en not_active IP Right Cessation
- 2005-12-14 DE DE602005015617T patent/DE602005015617D1/de not_active Expired - Lifetime
- 2005-12-14 CN CN2005800432057A patent/CN101080402B/zh not_active Expired - Fee Related
- 2005-12-14 EP EP05818265A patent/EP1828166B1/en not_active Expired - Lifetime
- 2005-12-14 RU RU2007121222/04A patent/RU2388758C2/ru not_active IP Right Cessation
- 2005-12-14 DK DK05818265T patent/DK1828166T3/da active
- 2005-12-14 CA CA002589525A patent/CA2589525A1/en not_active Abandoned
- 2005-12-14 ES ES05818265T patent/ES2328836T3/es not_active Expired - Lifetime
- 2005-12-14 JP JP2007546173A patent/JP5042849B2/ja not_active Expired - Fee Related
- 2005-12-14 HR HR20090489T patent/HRP20090489T1/hr unknown
- 2005-12-14 SI SI200530774T patent/SI1828166T1/sl unknown
- 2005-12-14 PL PL05818265T patent/PL1828166T3/pl unknown
- 2005-12-14 BR BRPI0519057-6A patent/BRPI0519057A2/pt not_active IP Right Cessation
- 2005-12-14 KR KR1020077013343A patent/KR20070090921A/ko not_active Ceased
- 2005-12-14 SA SA05260406A patent/SA05260406B1/ar unknown
- 2005-12-14 US US11/793,358 patent/US8129412B2/en not_active Expired - Fee Related
- 2005-12-14 WO PCT/GB2005/004811 patent/WO2006064218A1/en not_active Ceased
- 2005-12-15 TW TW094144382A patent/TW200634001A/zh unknown
- 2005-12-15 AR ARP050105275A patent/AR051797A1/es not_active Application Discontinuation
-
2007
- 2007-05-31 IL IL183590A patent/IL183590A0/en unknown
- 2007-06-12 ZA ZA200705068A patent/ZA200705068B/xx unknown
- 2007-07-09 NO NO20073550A patent/NO20073550L/no not_active Application Discontinuation
-
2009
- 2009-09-17 CY CY20091100960T patent/CY1109376T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0407618A (pt) | derivados de tiazole amino substituidos com cicloalquilo contendo n e composições farmacêuticas para inibição da proliferação celular e métodos para a sua utilização | |
| EA200970595A1 (ru) | Производные замещенных индазолов, активные в качестве ингибиторов киназ | |
| BR0010520A (pt) | Novos compostos farmaceuticamente ativos | |
| DK1611088T3 (da) | Hydroxymater som terapeutiske midler | |
| MA31685B1 (fr) | Nouveaux derives de 6-triazolopyridazine-sulfanyl benzothiazole et benzimidazole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met | |
| BRPI0410727A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| EA201101671A1 (ru) | Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина | |
| ECSP088869A (es) | Derivados de 2-pirazinona para el tratamiento de enfermedades o condiciones en donde resulta beneficiosa la inhibición de la actividad de la elastasa neutrofílica | |
| YU65804A (sh) | Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze | |
| NO20080865L (no) | Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer | |
| BRPI0720220B8 (pt) | derivado de quinolina, sua composição farmacêutica, seu uso, seu processo de preparação, combinação e produto compreendendo o mesmo | |
| BRPI0517263A (pt) | novos derivados de sulfonamida como moduladores do receptor de glicocorticóide para o tratamento de doenças inflamatórias | |
| EA200501332A1 (ru) | Производные пиримидин-4-она и их применение в качестве модуляторов киназы p38 | |
| MA31873B1 (fr) | Inhibiteurs de la peptide déformylase | |
| BRPI0512974A (pt) | novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas | |
| BRPI0706992C8 (pt) | composto de fórmula (i) e formulação farmacêutica | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| BRPI0409498A (pt) | uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para preparação de um composto | |
| BRPI0809542A8 (pt) | Compostos derivados de indol tendo atividade de inibição de cpla2, composição farmacêutica, e métodos de produção dos referidos compostos | |
| BRPI0719920B8 (pt) | derivado de quinolina, sua composição farmacêutica, seu uso, seu processo de preparação, combinação e produto compreendendo o mesmo e composto intermediário | |
| BR0313727A (pt) | Derivados de isoquinolina como inibidores de metaloproteinase da matriz | |
| BR112022021748A2 (pt) | Compostos e composições para inibir a atividade de hif2a e seus métodos de uso | |
| BRPI0512252A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto | |
| EP4635494A3 (en) | AMIDO HETERO-ROMATIC COMPOUNDS | |
| BRPI0517259A (pt) | novos derivados de sulfonamida como moduladores do receptor de glicocorticóide para o tratamento de doenças inflamatórias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014. |